Technical and Clinical Characterization of the Bio-PTH (1-84) Immunochemiluminometric Assay and Comparison with a Second-Generation Assay for Parathyroid Hormone

Clinical Chemistry

Volumn 50, Issue 2, 2004, Pages 385-390

  Inaba, Masaaki ^a   Nakatsuka, Kiyoshi ^a   Imanishi, Yasuo ^a   Watanabe, Masakazu ^b   Mamiya, Yuji ^b   Ishimura, Eiji ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE ANALOG; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BONE METASTASIS; CALIBRATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEMODIALYSIS; HORMONE DETERMINATION; HUMAN; HYPOPARATHYROIDISM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; PAGET BONE DISEASE; PRIMARY HYPERALDOSTERONISM; QUANTITATIVE ASSAY; STONE FORMATION; STORAGE;

BLOOD SPECIMEN COLLECTION; BONE DISEASES, METABOLIC; CALCIUM; CHEMILUMINESCENT MEASUREMENTS; HUMANS; IMMUNOASSAY; PARATHYROID HORMONE; REFERENCE VALUES;

EID: 0742287008     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.026831     Document Type: Article

References (15)

1. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, et al. Non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998;44:805-9.
2. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000;58:753-61.
3. Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E, Greenwalt A, et al. Metabolism of immunoreactive parathyroid hormone in the dog: the role of the kidney and the effects of chronic renal disease. J Clin Invest 1975;56:39-48.
4. Habener JF. Kemper B, Potts JT Jr. Calcium-dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores. Endocrinology 1975;97:431-41.
5. Chu LL, MacGregor RR, Anast CS, Hamilton JW, Cohn DV. Studies on the biosynthesis of rat parathyroid hormone and proparathyroid hormone: adaptation of the parathyroid gland to dietary restriction of calcium. Endocrinology 1973;93:915-24.
6. Guthlie E, Liu J, Cody C, Hutchnson JS, Wong J, Carlton E, et al. Development of an automated assay that measures PTH with no crossreactivity to non-(1-84) PTH [Abstract]. 83rd Annual Meeting of the Endocrine Society. Chevy Chase, MD: Endocrine Society, 2001;437.
7. Hatakeyama Y, Mizunashi K, Furukawa Y, Yabuki S, Sato Y, Igarashi T. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I. J Clin Endocrinol Metab 2003; 88:2250-5.
8. Malluche HH, Mawad H, Trueba D, Monier-Faugere M-C. Parathyroid hormone assays - evolution and revolutions in the care of dialysis patients. Clin Nephrol 2003;59:313-8.
9. Inaba M, Morii H, Katsumata T, Goto H, Ishimura E, Kawagishi T, et al. Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats. J Nutr 2000;130:1543-7.
10. Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 2002;39:1261-9.
11. Brossard J-H, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 2000;46:5;697-703.
12. Brossard J-H, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996;81:3923-9.
13. Diveti P, John MR, Juppner H, Bringhurst FR. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type I PTH/PTHrP receptor. Endocrinology 2002;143:171-6.
14. D'Armour P, Labelie F, Lecavalier L, Plouride V, Harvey D. Influence of serum Ca concentration on circulating molecular forms of PTH in three species. Am J Physiol 1986;251:E680-7.
15. D'Armour P, Palardy J, Bashall G, Malette LE, De Lean A, Lepage R. Modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab 1992;74:525-32.